Patient Capital Management’s Precigen PGEN Stock Holding History

Patient Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109M	Buy	19,036,976 +1,219,589	+7%	+$5.27M	3.56%	12
2026 Q1	$69M	Sell	17,817,387 -856,079	-5%	-$3.51M	2.52%	18
2025 Q4	$78.1M	Sell	18,673,466 -7,787,382	-29%	-$30.1M	3.01%	14
2025 Q3	$87.1M	Buy	26,460,848 +10,192,107	+63%	+$28.8M	3.48%	12
2025 Q2	$23.1M	Sell	16,268,741 -1,103,560	-6%	-$1.57M	1.04%	32
2025 Q1	$25.9M	Sell	17,372,301 -508,945	-3%	-$801K	1.33%	30
2024 Q4	$20M	Sell	17,881,246 -56,448	-0.3%	-$48.1K	0.92%	32
2024 Q3	$17M	Sell	17,937,694 -236,964	-1%	-$299K	0.83%	34
2024 Q2	$28.7M	Buy	18,174,658 +721,203	+4%	+$1.05M	1.53%	28
2024 Q1	$25.3M	Buy	17,453,455 +1,469,755	+9%	+$2.11M	1.23%	34
2023 Q4	$21.4M	Buy	15,983,700 +2,230,524	+16%	+$2.62M	1.13%	32
2023 Q3	$19.5M	Buy	13,753,176 +2,509,616	+22%	+$3.56M	1.15%	34
2023 Q2	$12.9M	Buy	11,243,560 +9,779,800	+668%	+$11.5M	0.72%	33
2023 Q1	$1.55M	Buy	1,463,760 +665,560	+83%	+$960K	0.69%	37
2022 Q4	$1.21M	Buy	798,200 +500,000	+168%	+$860K	0.59%	39
2022 Q3	$632K	Hold	298,200	–	–	0.32%	41
2022 Q2	$400K	Hold	298,200	–	–	0.18%	42
2022 Q1	$629K	Hold	298,200	–	–	0.21%	45
2021 Q4	$1.11M	Buy	+298,200	New	+$1.28M	0.32%	43

Other funds holding PGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

Patient Capital Management's PGEN Position: Q2 2026 in Review

Patient Capital Management increased its Precigen (PGEN) stake by 6.8% in Q2 2026, buying an estimated $5.27M and bringing the position to 19,036,976 shares worth $109M. The position accounts for 3.56% of the portfolio, ranked #12.

Patient Capital Management first reported a position in PGEN in Q4 2021 and has held it in 19 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Patient Capital Management held 19,036,976 shares of Precigen worth $109M as of Q2 2026.
Patient Capital Management bought 1,219,589 Precigen shares in Q2 2026, an estimated $5.27M.
Precigen made up 3.56% of Patient Capital Management's portfolio in Q2 2026, its #12 holding.
Patient Capital Management first reported a position in Precigen in Q4 2021 and has held it in 19 quarters since.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.